tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
GT Biopharma's activity chart (see below) currently has 12 price targets and 15 ratings on display.
Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 275 days.
Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 08-Aug-2023. First documented stock forecast 17-Mar-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-May-2021
3 years 2 months 4 days ago
(08-Aug-2023)
2/3 (66.67%)
$-282.98 (-68.94%)
224
Hold Since 04-Jan-2023
$52.5
$45.82 (685.93%)
$52.5
3 years 2 months 5 days ago
(07-Aug-2023)
3/5 (60%)
$-157.5 (-75.00%)
466
Buy Since 13-Apr-2021
$450
$443.32 (6636.53%)
$19500.05
4 years 8 months 18 days ago
(24-Jan-2022)
1/3 (33.33%)
$-1635 (-78.42%)
410
Buy
$26
$25.74 (9900.00%)
5 years 3 months 18 days ago
(24-Jun-2021)
0/1 (0%)
$11.72 (82.07%)
What is GTBP (GT Biopharma) average time for price targets to be met?
Which analyst most recently updated their price target on GTBP (GT Biopharma)?
Which analyst has the current lower performing score on GTBP (GT Biopharma) with a proven track record?
Which analyst has the most public recommendations on GTBP (GT Biopharma)?
Which analyst is the currently most bullish on GTBP (GT Biopharma)?
Which analyst is the currently most reserved on GTBP (GT Biopharma)?
